Xtant Medical Holdings (XTNT) EBT Margin Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,427.00 |
| Jun 30, 2025 | 3,401.00 |
| Mar 31, 2025 | 1,682.00 |
| Dec 31, 2024 | -60.00 |
| Sep 30, 2024 | -596.00 |
| Jun 30, 2024 | -16.00 |
| Mar 31, 2024 | 105.00 |
| Dec 31, 2023 | 29,185.00 |
| Sep 30, 2023 | 4,596.00 |
| Jun 30, 2023 | 1,606.00 |
| Mar 31, 2023 | 1,778.00 |
| Dec 31, 2022 | 8,898.00 |
| Sep 30, 2022 | 2,674.00 |
| Jun 30, 2022 | 3,418.00 |
| Mar 31, 2022 | 1,011.00 |
| Dec 31, 2021 | 78.00 |
| Sep 30, 2021 | 921.00 |
| Jun 30, 2021 | 1,935.00 |
| Mar 31, 2021 | 2,469.00 |
| Dec 31, 2020 | 2,750.00 |
| Sep 30, 2020 | 2,998.00 |
| Jun 30, 2020 | 471.00 |
| Mar 31, 2020 | 1,662.00 |
| Dec 31, 2019 | 3,153.00 |
| Sep 30, 2019 | 2,153.00 |
| Jun 30, 2019 | 1,922.00 |
| Mar 31, 2019 | 1,109.00 |
| Dec 31, 2018 | -25,692.00 |
| Sep 30, 2018 | 3,693.00 |
| Jun 30, 2018 | 348.00 |
| Mar 31, 2018 | -992.00 |
| Dec 31, 2017 | -4,223.00 |
| Sep 30, 2017 | -1,377.00 |
| Jun 30, 2017 | -5,429.00 |
| Mar 31, 2017 | -1,355.00 |
| Dec 31, 2016 | 3,004.00 |
| Sep 30, 2016 | 1,985.00 |
| Jun 30, 2016 | -1,846.00 |
| Mar 31, 2016 | -10,852.00 |
| Dec 31, 2015 | 10,148.00 |
| Sep 30, 2015 | 18,400.00 |
| Jun 30, 2015 | 3,610.00 |